Dr Ruth Davis

Consultant Clinical Oncologist

MBBS, MRCP, FRCR

I graduated from University College London Medical School in 1998 before working as a Junior Doctor in a number of hospitals including Mount Vernon and Charing Cross. I completed my clinical oncology training at Southampton University Hospitals Trust prior to my appointment as a Consultant at the Royal Berkshire Hospital, Reading in 2012.

I am the Radiotherapy Clinical Lead at the Berkshire Cancer Centre, Royal Berkshire Hospital, Reading. I am very keen to push forward new radiotherapy technologies, especially those that reduce toxicity to normal tissue and achieve better outcomes for patients. In particular I was involved in implementation of the breath hold breast radiotherapy technique in Reading and IMRT for brain and head and neck patients.

I am College Tutor, supervising training for clinical oncology trainees in Berkshire, and am involved with the regional training programme and national recruitment.

I am a keen participant in clinical research and am a Principal Investigator for a number of trials across Berkshire including the Fast Forward Breast Radiotherapy trial which compares standard radiotherapy with a shorter more intense course of treatment; Bridging the Age Gap which looks at treatment options for older breast cancer patients and Horizons which documents the experiences of our younger breast cancer patients.

I am a member of the UK Breast Cancer Group.

Read more...

Treatment information

Some of the principal treatments carried out by Dr Ruth Davis at Spire include:

Oncology

Other treatments

Specialties:

  • Breast cancer
  • Adult brain
  • Skull base and spinal cord tumours

Treatments:

  • Radiotherapy
  • Biological and immunotherapy
  • Hormone treatment

Get in touch

Important information about COVID-19 tests

COVID-19 testing or antibody tests are not available as a standalone service at Spire Dunedin Hospital.

143946
True
consultant

Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

We will use your personal information to process your enquiry. For further information, please see our privacy policy.

Submit my enquiry

Additional information


Articles

Erlotinib in the Treatment of Patients with Multiple Metastases from Non-small Cell Lung Cancer – Clinical Oncology Journal
Nov 2013

I sing in a number of choirs including in the BBC4 documentary Vivaldi’s Women.

I am on the Steering Committee for, and am an investor in Windsor Oncology Centre with Genesis Care. I have previously received honoraria from Roche and previous sponsorship from Novartis.
Private secretary Donna Gardner
Private secretary telephone 0118 955 3531
Private secretary email Donna.gardner@spirehealthcare.com